Northern Trust’s Moleculin Biotech MBRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-3,573
| Closed | -$46K | – | 4455 |
|
2023
Q4 | $46K | Hold |
3,573
| – | – | ﹤0.01% | 4248 |
|
2023
Q3 | $22.9K | Hold |
3,573
| – | – | ﹤0.01% | 4309 |
|
2023
Q2 | $31K | Hold |
3,573
| – | – | ﹤0.01% | 4323 |
|
2023
Q1 | $51.5K | Buy |
3,573
+485
| +16% | +$6.98K | ﹤0.01% | 4263 |
|
2022
Q4 | $49.1K | Hold |
3,088
| – | – | ﹤0.01% | 4290 |
|
2022
Q3 | $49K | Hold |
3,088
| – | – | ﹤0.01% | 4327 |
|
2022
Q2 | $67K | Sell |
3,088
-294
| -9% | -$6.38K | ﹤0.01% | 4319 |
|
2022
Q1 | $90K | Hold |
3,382
| – | – | ﹤0.01% | 4382 |
|
2021
Q4 | $94K | Hold |
3,382
| – | – | ﹤0.01% | 4440 |
|
2021
Q3 | $152K | Hold |
3,382
| – | – | ﹤0.01% | 4273 |
|
2021
Q2 | $186K | Hold |
3,382
| – | – | ﹤0.01% | 4183 |
|
2021
Q1 | $207K | Buy |
3,382
+2,391
| +241% | +$146K | ﹤0.01% | 4108 |
|
2020
Q4 | $71K | Hold |
991
| – | – | ﹤0.01% | 4182 |
|
2020
Q3 | $72K | Buy |
991
+47
| +5% | +$3.42K | ﹤0.01% | 4038 |
|
2020
Q2 | $82K | Buy |
944
+207
| +28% | +$18K | ﹤0.01% | 3962 |
|
2020
Q1 | $40K | Hold |
737
| – | – | ﹤0.01% | 3987 |
|
2019
Q4 | $61K | Hold |
737
| – | – | ﹤0.01% | 4022 |
|
2019
Q3 | $74K | Buy |
737
+205
| +39% | +$20.6K | ﹤0.01% | 3986 |
|
2019
Q2 | $60K | Hold |
532
| – | – | ﹤0.01% | 4054 |
|
2019
Q1 | $39K | Hold |
532
| – | – | ﹤0.01% | 4063 |
|
2018
Q4 | $50K | Buy |
532
+277
| +109% | +$26K | ﹤0.01% | 4051 |
|
2018
Q3 | $37K | Hold |
255
| – | – | ﹤0.01% | 4166 |
|
2018
Q2 | $41K | Buy |
255
+105
| +70% | +$16.9K | ﹤0.01% | 4143 |
|
2018
Q1 | $24K | Hold |
150
| – | – | ﹤0.01% | 4153 |
|
2017
Q4 | $25K | Buy |
150
+26
| +21% | +$4.33K | ﹤0.01% | 4137 |
|
2017
Q3 | $27K | Hold |
124
| – | – | ﹤0.01% | 4127 |
|
2017
Q2 | $21K | Hold |
124
| – | – | ﹤0.01% | 4178 |
|
2017
Q1 | $13K | Buy |
+124
| New | +$13K | ﹤0.01% | 4184 |
|